These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-004727-36 Influence of low-dose i.v. growth hormone treatment together with glutamine supplementation in late-phase critically ill patient after multiple injury. A pilot study. not-yet-due
Ongoing 2005-002686-36 Developmental pharmacokinetics and pharmacogenetics aspects of analgosedation by tramadol of newborns, infants and older children treated at the intensive care unit not-yet-due
Ongoing 2005-002723-13 Farmakokinetika gentamicinu, predikce dávkování u nedonošených a donošených novorozenců. (Pharmacokinetics of gentamicin, dosage prediction in term and preterm neonates. not-yet-due
No trial status on register 2006-006867-22 Treatment of proteinuria with angiotensin-converting enzyme inhibitor in children after renal transplantation bad-data
Not reported 2006-007024-34 Treatment of alveolar osteitis using ozonated water 2010-12-31 due-trials
Ongoing 2007-000043-10 Combination of alpha2-adrenoreceptor agonists, opioids and ketamine for improving of perioperative course not-yet-due
Ongoing 2007-002893-76 MEtabolic Therapy with Trimetazidine in Acute heart failure: an open pilot randomized trial (The METTA – PRAGUE 10 Trial) not-yet-due
Ongoing 2009-015403-95 A pilot trial of noninvasive assessment of methotrexate hepatotoxicity in the course of pharmacokinetically guided pharmacotherapy of psoriasis with methotrexate and folic acid not-yet-due
Exempt Terminated 2009-017259-91 Phase I/II clinical trial: Immunotherapy of prostate cancer patients in biochemical relapse with dendritic cell-based vaccine Fáze I/II klinické studie imunoterapie karcinomu prostaty ve stádiu bio... not-yet-due
Exempt Terminated 2009-017295-24 Phase I/II clinical trial:Immunotherapy of hormone-refractory prostate cancer patients with dendritic cell-based vaccine (Fáze I/II klinické studie imunoterapie hormonálně refrakterního karcinomu pros... 2014-03-31 not-yet-due
Ongoing 2010-024438-52 Impaired sense of smell and its conservative tratment in patients with chronic rhinosinusitis Hodnocení poruchy čichu a její medikamentózní léčba u pacientů s chronickou polypózní rinosinusitidou not-yet-due
Reported results 2011-001132-30 Non-invasive parameters in the evaluation of portal hypertension in patients with liver cirrhosis and their significance for the evolution of cardial complications. 2014-12-31 due-trials
Completed, but no date 2011-001856-12 Early assessment of effectivness of neoadjuvant chemotherapy for carcinoma of the esophagus and esophago-gastric junction using FDG-PET/CT. bad-data
Not reported 2011-001956-12 Monitoring of MxA mRNA Expression as a Marker of Rresponse to Interferon ß Therapy in Patients with Multiple Sclerosis. 2015-01-19 due-trials
Exempt 2012-001335-31 Adoptive transfer of CMV specific CD8+ T-cells to treat CMV infection after transplantation Adoptivní transfer CMV-specifických CD8+ T lymfocytů k léčbě CMV infekce po transplantaci not-yet-due
Ongoing 2012-004406-10 The use of oxygen and hydrogen mixture for inhalation to prevent ischaemia-reperfusion injury Inhalační aplikace směsi kyslíku a vodíku k prevenci ischemicko-reperfuzního poškození not-yet-due
Not reported 2012-005599-33 Utilization of Autologous Multipotent Mesenchymal Stem Cells in the Management of the Large Skeletal Defects during Revision Total Hip Arthroplasty: a Prospective, Non-randomized, Open-Label Study to ... 2016-11-17 due-trials
Ongoing 2013-001639-38 Contribution to verify the effectiveness of adding granulocyte stimulating factor (G-CSF) to therapy 5 - Azacitidine patients with the high risk Myelodysplastic syndrome. Příspěvek k ověření účinn... not-yet-due
Not reported 2013-003324-36 Kinetically guided removal of plazma pegylated liposomal doxorubicin to enhance the benefit of cytostatic therapy of patients with ovarian cancer. Kineticky řízené odstranění plazmatického pegylova... 2016-01-30 due-trials
Ongoing 2013-004203-39 A randomized, 12 months, active controlled study of the efficacy of repeated doses of intravitreal aflibercept in subjects with prolipherative diabetic retinopathy Randomizovaná, 12 měsíční, aktivn... not-yet-due
Ongoing 2016-000926-21 Innovation of method cryopreservation for clinical use autologous multipotent mesenchymal stem cells (MSCs) for treatment of extensive skeletal defects in revision surgery of total hip arthroplasty+ ... not-yet-due
Ongoing 2016-000971-26 Liposoms (drug delivery systems) in kinetically guided therapy of ovarian platinum-resistant carcinoma with doxorubicin using plasmafiltration Lipozomy (drug delivery systems) v kineticky řízené lé... not-yet-due
Not reported 2016-004097-17 Evaluation of changes in concentrations of memantine in the cerebrospinal fluid of patients with Alzheimer´s disease. Sledování změn koncentrace memantinu v mozkomíšním moku pacientů S Alzheimerov... 2017-12-28 due-trials
Not reported 2017-003586-94 Monitoring of changes in donepezil concentrations, biomarkers of oxidative stress and activity of acetylchonesterase in the cerebrospinal fluid and plasma of patients with Alzheimer disease. Sledov... 2021-08-20 due-trials
Not reported 2018-000109-22 Monitoring of efficacy of antibiotic prophylaxis in thoracic surgery Monitorace účinnosti antibiotické profylaxe u hrudní chirurgie 2018-12-02 due-trials
Ongoing 2018-002161-19 Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction not-yet-due
Ongoing 2020-000595-37 Pharmacokinetics and pharmacodynamics of levobupivacaine during continuous caudal epidural analgesia in newborns Farmakokinetika a farmakodynamika levobupivakainu u novorozenců během kontinuální ka... not-yet-due
Exempt 2020-003770-50 An Open-Label, Single/Multiple Ascending Dose Study to Assess the Pharmacokinetics, Efficacy, Safety and Tolerability of Inhalation Delivery of Hydroxychloroquine Sulfate (HCQ) in Healthy Volunteers a... not-yet-due
Ongoing 2021-001058-73 Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation - Prospective Randomised Study Brolucizumab vs. aflibercept pro retinální angiomatózní proliferaci – prospektivní randomizovaná st... not-yet-due
Ongoing 2021-002014-14 Antibody and cellular response 28 days after the first dose of COVID-19 vaccine (Moderna) and then 33 weeks after the second dose and 8-12 weeks after the third dose in clinically stable patients with... not-yet-due
Ongoing 2022-002330-13 The randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosis – on the search for means of improvement Randomizovaná,... not-yet-due